In literature in which detection of Chlamydia pneumoniae in the artery is described, the methods used were immunocytochemistry (ICC), polymerase chain reaction (PCR), electron microscopy, and isolation. These studies demonstrated the presence of the organism in atheromatous lesions. The organism was detected frequently by ICC and PCR in atheromatous tissues (∼50% of subjects) but rarely in normal arteries (∼1% of subjects). There has been poor correlation between detection and serology. Detection studies have been used to assess the etiologic role of C. pneumoniae in atherosclerosis and to determine whether C. pneumoniae infection contributes to acute cardiovascular events. Although these studies produced suggestive evidence of an etiologic role, the use of observational studies to obtain a definitive answer is difficult. Therefore, investigators are increasingly concentrating their efforts on studies that use animal models, in vitro cultured arterial cells, and therapeutic trials in humans to determine the pathogenic role of the organism in atherosclerosis.
In literature in which detection of Chlamydia pneumoniae in the artery is described, the methods used were immunocytochemistry (ICC), polymerase chain reaction (PCR), electron microscopy, and isolation. These studies demonstrated the presence of the organism in atheromatous lesions. The organism was detected frequently by ICC and PCR in atheromatous tissues (∼50% of subjects) but rarely in normal arteries (∼1% of subjects). There has been poor correlation between detection and serology. Detection studies have been used to assess the etiologic role of C. pneumoniae in atherosclerosis and to determine whether C. pneumoniae infection contributes to acute cardiovascular events. Although these studies produced suggestive evidence of an etiologic role, the use of observational studies to obtain a definitive answer is difficult. Therefore, investigators are increasingly concentrating their efforts on studies that use animal models, in vitro cultured arterial cells, and therapeutic trials in humans to determine the pathogenic role of the organism in atherosclerosis.
The current interest in the role of infection in atherosclerosis was rekindled by seroepidemiologic studies and detection of the organism in atherosclerotic lesions, which demonstrated an association between Chlamydia pneumoniae and atherosclerosis. Since Shor et al. [1] first reported detection of C. pneumoniae in coronary atheromatous plaques by electron microscopy (EM) and immunocytochemistry (ICC), nearly 50 published papers and abstracts have confirmed or refuted these original findings. The methods of detection used include antigen detection by ICC or immunofluorescence antibody technique, DNA detection by polymerase chain reaction (PCR) and in situ hybridization, EM, and isolation. While a small number of studies failed to detect the organism, the great majority found high frequencies of organisms in atherosclerotic lesions. These findings set the stage for investigations into the etiologic role of C. pneumoniae in atherosclerosis by human therapeutic trials, in vitro studies using vascular cells, and experimental animal models of C. pneumoniae infection and atherosclerosis as discussed separately in this symposium.
We reviewed 30 published papers on the detection of C. pneumoniae in vascular tissues and summarize our findings in this report. The studies conducted at the University of Washington [2] [3] [4] [5] [6] [7] [8] [9] [10] and by other investigators [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] are analyzed separately and compared with each other.
Materials and Methods
Methods of detection have included detection of antigens and DNA, EM, and isolation.
Detection of antigen. The great majority of the studies used the standard ICC avidin-biotinylated immune complex (ABC) method [29] . One study used the immunofluorescence antibody technique that requires frozen sections [12] . The antibodies used were as follows: (1) mouse monoclonal antibodies against C. pneumoniae RR-402 and TT-401 (target antigens unknown) [30, 31] ) and AY-6 (recognizes the 53-kDa protein) [32] ); (2) Chlamydia genus-specific lipopolysaccharide CF-2 [30] ; and (3) Chlamydia trachomatis 60-kDa heat-shock protein [33, 34] .
Detection of DNA. The great majority of the studies used the standard PCR technique. A few also used in situ hybridization. The most commonly used primers specific against C. pneumoniae genes were the primer sets that amplify the 438-base pair (bp) fragment of the C. pneumoniae gene [35] , the 463-bp fragment of the 16S rRNA gene [36] , and various bp fragments of the outer membrane protein-1 gene [37] .
EM. Transmission EM was used in conjunction with ICC and/ or PCR. No studies used immune EM.
Isolation. For isolation, the standard chlamydial cell culture method using HL [38, 39] or HEp-2 [40] cells was used. One laboratory used serum-free culture medium and multiple passages [18, 41] .
Tissue samples. A variety of tissue samples from autopsy, surgery, atherectomy, and endarterectomy (fresh, frozen, or formalinfixed and paraffin embedded) were examined. The most studied arteries were the coronary and carotid arteries and the aorta. Other arteries and veins were also examined. The vessels studied included the iliac, femoral, and popliteal artery, the saphenous vein, and the internal mammary artery of coronary bypass.
Results
Detection rates. C. pneumoniae was detected by ICC, PCR, or both in atheromatous tissues from 50% of subjects but was rarely found (1%) in normal vascular tissues (table 1). One problem encountered in these studies was the difficulty in obtaining normal arterial tissues from persons with no atherosclerosis. The PDAY (Pathological Determinants of Athero- sclerosis in Youth) study, in which arterial tissues were obtained from subjects aged 15-35 years who died primarily of traumatic causes [5] , provided a unique opportunity to compare coronary arteries with atherosclerosis with specimens from persons of similar age without evident atherosclerosis. C. pneumoniae was detected by ICC or PCR in 6 (86%) of 7 specimens with atheromatous plaques and 2 (18%) of 11 coronary segments with intimal thickening. No organisms were detected in the 31 normal-appearing coronary segments.
Arteries in which C. pneumoniae was detected. The lesions in which C. pneumoniae was detected were from the coronary artery, including coronary bypass of the saphenous vein, and internal mammary, carotid, pulmonary, iliac, femoral, and popliteal arteries and the aorta. C. pneumoniae was also detected in nonrheumatic aortic stenotic valves [42] .
Age differences in detection. The youngest age at which C. pneumoniae was detected in the artery was 15 years [20] . Our PDAY study [5] showed a higher detection rate in subjects 25-34 years old (7 [26%] of 27 subjects) than in those 15-24 years old (1 [5%] of 22 subjects) (table 2). However, the study on organ transplant patients by Taylor-Robinson et al. [20] (table 2) did not find a difference by age groups (ages, 15-60 years).
Variability in detection. Variability in detection rates was found among investigators, arteries, and detection methods used.
Variability in detection rates among studies and investigators. In our 9 studies [2] [3] [4] [5] [6] [7] [8] [9] [10] , the detection rates ranged from 13% to 69% (mean, 54%; table 1). In 18 studies by other investigators [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] , detection rates were 0%-100% with a mean detection frequency of 43% (table 1) . The four lowest detection rates of the 18 studies were 0% [19] , 0% [21] , 2% [15] , and 8% [28] . All of these studies used PCR alone.
Variability in detection rates among sequential tissue sections. A patchy distribution of C. pneumoniae in lesions has been observed in multiple sections from the same tissue samples and of multiple arteries from the same persons. In our studies, 113 (68%) of 167 sections of positive tissues from 51 (31%) of 166 positive subjects were positive by ICC when more than 1 tissue section was examined (table 3). In the study by Thomas et al. [25] , which examined postmortem coronary artery samples by PCR, 26 (79%) of 33 subjects were positive for C. pneumoniae. When the presence of C. pneumoniae among 3 coronary main branches was analyzed, one-third of the subjects had the organism in 1, 2, or 3 arteries (table 3) .
Variability in detection rates by method. A lack of correlation between ICC and PCR has been noted. In our four studies [2, 4, 8, 10] in which the same tissues were tested by both ICC and PCR, of specimens that were positive by either method, 25%-50% of the specimens were positive by both tests (table 4) . When the detection rates of ICC and PCR were compared for all studies, ICC had higher rates than PCR (table 5) . This finding is contrary to the sensitivity of the two tests, since PCR is more sensitive than ICC. The reason for this discrepancy has been attributed to the presence of tissue inhibitors for PCR (see Discussion).
Difficulty in recovery of live organisms from atheromatous tissue. C. pneumoniae has been isolated from coronary and carotid artery atheromatous tissue by three independent groups (table 6) [8, 11, 18, 26] . However, culture of the organism from the lesion has been the most difficult to achieve of the four detection methods. Being able to isolate the organism is an important step in the investigation of the etiologic role of C. pneumoniae in atherosclerosis.
Lack of correlation between detection and serology. Lack of correlation between detection and serology has been noted. In our studies, the organism was detected in seronegative subjects. However, the organism is not always detected in antibodypositive subjects. The correlation between the presence of the organism in the lesion and high IgG titers or presence of IgM antibody indicative of current infection has been poor. In addition, correlation of detection rates with any IgG antibody titer is poor. In our five studies in which detection and antibody titers were compared, only one study showed a positive correlation between microimmunofluorescence antibody and the (table 7) . In general, detection rates are higher in specimens with severe than with mild disease. However, few studies had statistically significant differences [17, 26] .
Discussion
C. pneumoniae was detected by ICC, PCR, or both in atheromatous lesions from 50% of persons studied. This figure may be an underestimation because only a small amount of the tissue sample is examined (usual size, 4-mm sections for ICC and 8-mm sections for PCR). In addition, the distribution of chlamydial organisms in atherosclerotic lesions is localized or patchy. This characteristic pathology is seen in chronic infection of the conjunctiva (trachoma) and salpinx (tubal infertility) with C. trachomatis and in interstitial pneumonitis with C. pneumoniae in humans and experimental animals [43] . The distribution of C. pneumoniae-positive cells in atheromatous lesions by ICC stain is also characteristically localized and patchy. This observation is apparent from staining of serial tissue sections by ICC (table 3) . The issue of what percentage of tissues examined contain C. pneumoniae is less important than whether C. pneumoniae is or is not present in atheromatous lesions. Even though a few studies failed to detect the organism, we conclude that C. pneumoniae is frequent in atheromatous lesions.
The organism is detected in the major arterial system and in association with various clinical manifestations of vascular diseases including coronary heart disease (angina and myocardial infarction) [4, 12, 18, 23, 25, 27] , carotid stenosis (transient ischemic attack and stroke) [6, 8, 17, 22] , thrombosis of the arteries of the lower extremity (claudication) [7, 23] , and aortic aneurysm and rupture [13, 14, 16] . Whether C. pneumoniae infection of atheroma can trigger acute events is still disputable. However, the fact that C. pneumoniae is frequently present in atheromatous lesions and that atherosclerosis is the underlying cause of these clinical events warrants further investigation into whether C. pneumoniae contributes to these acute events.
Detection varies widely among studies and investigators. Possible reasons (rather than reflecting true positivity or geographic differences [15] ) include the localized nature of chlamydial pathology as discussed above [43] , the small amount of atheromatous tissue examined, and the nonconformity in laboratory procedures. Variability in detection between ICC and PCR is noteworthy because studies that used PCR had lower detection rates than those that used ICC. The lower detection rate with PCR than ICC has been attributed to the difficulty in extracting DNA from atheromatous tissue, especially from calcified lesions, and to the presence of inhibitors for PCR in atheromatous tissues. Wong et al. [24] found that atherosclerotic vessels are more likely to contain PCR inhibitors than are nonatherosclerotic vessels. Thomas et al. [25] showed that tissues with severe lesions tend to contain more inhibitors than tissues with mild lesions. Inhibitors were associated with the presence of lipid and calcification in tissue samples.
Difficulty in recovering live organisms from atheromatous tissues is not unique to C. pneumoniae. It is also difficult to isolate organisms from the eye (trachoma) and genitourinary tract (tubal infertility) in chronic C. trachomatis infection and from the respiratory tract in chronic C. pneumoniae lung infection. This problem is partly attributed to the suppression of [43] . It is possible that modifications in the isolation procedure may improve the sensitivity as discussed by Maass and colleagues (elsewhere this supplement) [18, 41] .
The lack of correlation between detection or bacteriologic diagnosis and serology in chronic chlamydial infection remains an unsolved paradox with no good explanation. Unlike acute infection, with definable serologic markers such as seroconversion, presence of IgM antibody, or four-fold rise or fall in IgG titers, serum IgG antibodies against chlamydial infection tend to persist many years due to the chronic nature of infection. Antibodies are also maintained by relapse or reinfection, which is common in chlamydial infection due to a weak and shortlasting immunity.
Detection studies have been used to elucidate the pathogenic role of C. pneumoniae in atherogenesis and to determine whether C. pneumoniae infection contributes to acute cardiovascular events [2-5, 10, 13, 17, 24, 26] . These studies have produced suggestive evidence that it does (table 7) . However, it would be difficult to use detection studies to obtain a definitive answer on an etiologic role, because establishment of the presence of the organism in the lesion is not sufficient to prove a pathogenic role.
In conclusion, numerous studies have demonstrated the presence of C. pneumoniae in atherosclerotic lesions. Further observational studies can only add to the current circumstantial evidence. For these reasons, research on the etiologic role of C. pneumoniae in atherogenesis has moved forward to animal model studies, human therapeutic trials, and in vitro studies using arterial cells as discussed elsewhere in this issue.
